Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA Endorses Proposed AMP Rule In Principle But Perhaps Not In Practice

Executive Summary

The Pharmaceutical Research and Manufacturers of America is supporting CMS' proposal to broadly define the "retail class of trade" for the purpose of calculating Medicaid average manufacturer prices, but raises concern about manufacturers' potential responsibility to track the various sales and price concessions through the drug distribution network

You may also be interested in...



ASPs For Bundled Drugs Might Be Improved With “Exceptions” Process – MedPAC

CMS should consider creating a process to allow revisions of Part B average sales prices for drugs sold through bundled arrangements, to enhance the accuracy of ASPs, the Medicare Payment Advisory Commission suggests in comments to CMS

ASPs For Bundled Drugs Might Be Improved With “Exceptions” Process – MedPAC

CMS should consider creating a process to allow revisions of Part B average sales prices for drugs sold through bundled arrangements, to enhance the accuracy of ASPs, the Medicare Payment Advisory Commission suggests in comments to CMS

Medicaid AMPs Exclude PBM Discounts Outside Of Mail Order – Final Rules

CMS has been persuaded to exclude pharmacy benefit manager price concessions, other than mail-order, from Medicaid AMPs, because PBMs do not take possession of drug products in most cases nor are their financial transactions easily tracked by manufacturers

Related Content

UsernamePublicRestriction

Register

ID004339

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel